Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study)

Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update

(2023) Thomas Lehrnbecher et al.   JOURNAL OF CLINICAL ONCOLOGY

8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation

(2021) Thomas Lehrnbecher et al.   LANCET ONCOLOGY

Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)

(2020) Akash Kumar et al.   INDIAN JOURNAL OF PEDIATRICS

Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double‐blind placebo‐controlled trial

(2020) Satya Prakash et al.   PEDIATRIC BLOOD & CANCER

Delivering pediatric oncology services during a COVID‐19 pandemic in India

(2020) Rachna Seth et al.   PEDIATRIC BLOOD & CANCER

Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer

(2019) Tasnim Arif et al.   PEDIATRIC BLOOD & CANCER

Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia

(2019) Jagdish Prasad Meena et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

(2018) Hanine El Haddad et al.   Scientific Reports

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update

(2017) Thomas Lehrnbecher et al.   JOURNAL OF CLINICAL ONCOLOGY

Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial

(2016) Stella Sala Soares Lima et al.   ANNALS OF HEMATOLOGY

Systematic review of reduced therapy regimens for children with low risk febrile neutropenia

(2016) Jessica E. Morgan et al.   SUPPORTIVE CARE IN CANCER

Using Procalcitonin to Guide Antibiotic Therapy

(2016) Chanu Rhee   Open Forum Infectious Diseases

Antimicrobial resistance: a global multifaceted phenomenon

(2015) Francesca Prestinaci et al.   Pathogens and Global Health

Febrile Neutropenia: Outline of Management

(2012) Sapna Oberoi et al.   INDIAN JOURNAL OF PEDIATRICS

First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study

(2012) Eva Brack et al.   PEDIATRIC BLOOD & CANCER

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future

(2011) Philipp Schuetz et al.   BMC Medicine

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Randomized Control Trial Comparing Oral Amoxicillin-clavulanate and Ofloxacin With Intravenous Ceftriaxone and Amikacin as Outpatient Therapy in Pediatric Low-risk Febrile Neutropenia

(2009) Ajay Gupta et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

The Role of Procalcitonin in Febrile Neutropenic Patients: Review of the Literature

(2008) Y. Sakr et al.   INFECTION